Pembrolizumab Achieved pCR in Patient With Recurrent DDLPS

A new case report suggests that a high tumor mutational burden (TMB) and high tumor-associated macrophages (TAM) density in the tumor microenvironment (TME) may be predictors of a positive response to immune checkpoint inhibitors (ICIs) among…